China Drug Testing Market Size & Outlook, 2025-2030
The drug testing market in China is expected to reach a projected revenue of US$ 1,055.9 million by 2030. A compound annual growth rate of 6.7% is expected of China drug testing market from 2025 to 2030.
Quest Diagnostics Inc, Abbott Laboratories, QuidelOrtho Corp, Roche Holding AG ADR, Thermo Fisher Scientific Inc, Siemens Healthineers AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Labcorp Holdings Inc, Clinical Reference Laboratory, Cordant Health Solutions, Legacy Medical, Draegerwerk AG & Co KGaA, Omega Laboratories
Other key industry trends
In terms of revenue, China accounted for 5.2% of the global drug testing market in 2024.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Asia Pacific, China drug testing market is projected to lead the regional market in terms of revenue in 2030.
India is the fastest growing regional market in Asia Pacific and is projected to reach USD 653.1 million by 2030.
In China, drug abuse, especially alcohol and illicit drug abuse, is very common among young people. Moreover, the growth of China drug testing market can also be attributed to increasing number of product launches and growing availability of rapid test kits.
For instance, in March 2021, the Hong Kong police force deployed DrugWipe 6 S Ketamine for rapid screening tests for roadside drug screening. The device provides rapid screening for seven drugs—opiates, cannabis, amphetamines, cocaine, benzodiazepines, methamphetamines (MDMA, ecstasy), and ketamine.
The Chinese government is proactively taking steps to control the spread and consumption of illicit drugs in the country. As per the "Drug Control Law of the People's Republic of China," the National Narcotics Control Commission (NNCC) is responsible for monitoring, coordinating, and organizing national drug control work.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Drug Testing Market Outlook will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 36.71% in 2024.
Horizon Databook has segmented the China drug testing market based on consumables, instruments, rapid testing devices, services covering the revenue growth of each sub-segment from 2018 to 2030.
In China, drug abuse, especially alcohol and illicit drug abuse, is very common among young people. Moreover, the growth of China drug testing market can also be attributed to increasing number of product launches and growing availability of rapid test kits.
For instance, in March 2021, the Hong Kong police force deployed DrugWipe 6 S Ketamine for rapid screening tests for roadside drug screening. The device provides rapid screening for seven drugs—opiates, cannabis, amphetamines, cocaine, benzodiazepines, methamphetamines (MDMA, ecstasy), and ketamine.
The Chinese government is proactively taking steps to control the spread and consumption of illicit drugs in the country. As per the "Drug Control Law of the People's Republic of China," the National Narcotics Control Commission (NNCC) is responsible for monitoring, coordinating, and organizing national drug control work.
China Drug Testing Market Product Outlook (Revenue, USD Million , 2018-2030)
Consumables
Instruments
Rapid Testing Devices
Services
China Drug Testing Market Sample Type Outlook (Revenue, USD Million , 2018-2030)
Urine Samples
Oral Fluid Samples
Hair Samples
Other Samples
China Drug Testing Market Drug Type Outlook (Revenue, USD Million , 2018-2030)
Alcohol
Cannabis/Marijuana
Cocaine
Opioids
Amphetamine & Methamphetamine
LSD
Others
China Drug Testing Market End Use Outlook (Revenue, USD Million , 2018-2030)
Drug Testing Laboratories
Workplaces
Hospitals
Other
Reasons to subscribe to Drug Testing Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Drug Testing Market Outlook databook
Our clientele includes a mix of Drug Testing Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China Drug Testing Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into China Drug Testing Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.